1. Home
  2. AME vs ARGX Comparison

AME vs ARGX Comparison

Compare AME & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AME
  • ARGX
  • Stock Information
  • Founded
  • AME 1930
  • ARGX 2008
  • Country
  • AME United States
  • ARGX Netherlands
  • Employees
  • AME N/A
  • ARGX N/A
  • Industry
  • AME Industrial Machinery/Components
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AME Industrials
  • ARGX Health Care
  • Exchange
  • AME Nasdaq
  • ARGX Nasdaq
  • Market Cap
  • AME 39.2B
  • ARGX 35.2B
  • IPO Year
  • AME N/A
  • ARGX 2017
  • Fundamental
  • Price
  • AME $197.37
  • ARGX $605.92
  • Analyst Decision
  • AME Buy
  • ARGX Strong Buy
  • Analyst Count
  • AME 7
  • ARGX 21
  • Target Price
  • AME $206.17
  • ARGX $619.79
  • AVG Volume (30 Days)
  • AME 1.4M
  • ARGX 336.7K
  • Earning Date
  • AME 10-31-2024
  • ARGX 10-31-2024
  • Dividend Yield
  • AME 0.57%
  • ARGX N/A
  • EPS Growth
  • AME 3.98
  • ARGX N/A
  • EPS
  • AME 5.74
  • ARGX N/A
  • Revenue
  • AME $6,910,463,000.00
  • ARGX $1,908,659,000.00
  • Revenue This Year
  • AME $7.25
  • ARGX $61.99
  • Revenue Next Year
  • AME $5.23
  • ARGX $42.48
  • P/E Ratio
  • AME $34.39
  • ARGX N/A
  • Revenue Growth
  • AME 6.45
  • ARGX 85.56
  • 52 Week Low
  • AME $149.03
  • ARGX $327.73
  • 52 Week High
  • AME $197.83
  • ARGX $611.22
  • Technical
  • Relative Strength Index (RSI)
  • AME 76.74
  • ARGX 62.35
  • Support Level
  • AME $191.00
  • ARGX $558.15
  • Resistance Level
  • AME $196.70
  • ARGX $603.23
  • Average True Range (ATR)
  • AME 2.96
  • ARGX 12.95
  • MACD
  • AME 0.34
  • ARGX -0.41
  • Stochastic Oscillator
  • AME 97.49
  • ARGX 90.01

About AME AMETEK Inc.

Ametek Inc is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets, and generates major revenue. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. The majority of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

Share on Social Networks: